Nasdaq
ABCL
AbCellera Biologics Inc.
- Health Care
- Canada
- Listed 2020
- 1 day
- +10.3%
- 1 month
- −15.1%
- 1 year
- +58.5%
$6.53 · Mkt cap $1.92B
At the 6 Aug 2026 close
Nasdaq
AbCellera Biologics Inc.
$6.53 · Mkt cap $1.92B
At the 6 Aug 2026 close
AbCellera Biologics Inc. trades under the ticker ABCL on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $1.92B. The last closing price was $6.53, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +58.5%, and −15.1% over the past month. Returns are price returns and exclude dividends.
This page exists because ABCL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.